Aspen Pharmacare gained rights to manufacture medicines with Merck/MSD to improve access to pharmaceuticals in Africa.
2 reports, 2 independent
Updated Jul 26
Gone quiet
- Reports
- 2
- Developments
- 4
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Aspen Pharmacare gained rights to manufacture medicines with Merck/MSD to improve access to pharmaceuticals in Africa.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Adcock Ingram and Aspen Pharmacare are contributing to the establishment of a regional medical hub in sub-Saharan Africa.Sub-event
- Aspen Pharmacare was licensed to manufacture medicines in South Africa as of August 1, 2026.Sub-event
Aspen Pharmacare is a key African supplier, and generic manufacturing is based in India.1 source
SA company Aspen secured manufacturing rights from Merck/MSD for African medicine access.1 source
Keep exploring
The entities involved
-
South Africa
country in southern Africa
-
Aspen Pharmacare
multinational South African holding company for pharmaceutical concerns
Nothing else this week.
-
Merck KGaA
German multinational science and technology company
Related events
- National Treasury reports mineral royalties collected while mining companies trade on the JSE in South Africa.
- MTN Group operates across Africa, serves markets in the Middle East, and is headquartered in Johannesburg, South Africa.
- ASUS is focusing on the South African market, with Wayne Holt managing Southern sales.
- Merck KGaA and ABVC BioPharma are competing for investment as healthcare companies.
- Anheuser-Busch reported its financial results for South Africa, noting its trading presence in New York and on the JSE.
Coverage
Newest first; wire copies grouped- businessday.co.zaAspen positions itself as key African supplier of Merck HIV pill
- news24.comAspen secures right to manufacture revolutionary HIV prevention drug once approved | News24